Cargando…
PS159. Altered serum levels of matrix metalloproteinase-2, -9 in response to electroconvulsive therapy for mood disorders.
Autores principales: | Shibasaki, Chiyo, Takebayashi, Minoru, Itagaki, Kei, Abe, Hiromi, Kajitani, Naoto, Okada-Tsuchioka, Mami, Yamawaki, Shigeto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616755/ http://dx.doi.org/10.1093/ijnp/pyw043.159 |
Ejemplares similares
-
Altered Serum Levels of Matrix Metalloproteinase-2, -9 in Response to Electroconvulsive Therapy for Mood Disorders
por: Shibasaki, Chiyo, et al.
Publicado: (2016) -
Possible Association between Serum Matrix Metalloproteinase-9 (MMP-9) Levels and Relapse in Depressed Patients following Electroconvulsive Therapy (ECT)
por: Shibasaki, Chiyo, et al.
Publicado: (2017) -
PS127. Antidepressant amitriptyline activates matrix metalloproteinase in astroglial cells: involvement in glial cell line-derived neurotrophic factor expression.
por: Abe, Hiromi, et al.
Publicado: (2016) -
Serum levels of high mobility group box‐1 protein (HMGB1) and soluble receptors of advanced glycation end‐products (RAGE) in depressed patients treated with electroconvulsive therapy
por: Abe, Hiromi, et al.
Publicado: (2023) -
PS158. Factors associated with relapse after a response to electroconvulsive therapy in unipolar versus bipolar depression
por: Itagake, Kei, et al.
Publicado: (2016)